Among 41 patients with this rare and highly aggressive RCC subtype, the objective response rate (ORR) was 56% with the ...

And if you're looking for top dividend-paying companies to put your money in right now, let's consider two excellent ...

The overwhelming federal nature of this subject is apparent,” the lawsuit alleges. “States are not free to tinker with ...

A New Jersey pharmaceutical company filed a lawsuit in federal court last week challenging a new Maine law aimed to protect a ...

The two biggest weight-loss drugmakers have lost $252bn in value this year, as investor enthusiasm for obesity treatments ...

The executive order from President Donald Trump calls on the HHS' Office of the Assistant Secretary for Preparedness and ...

Ianalumab is a fully human monoclonal antibody designed to deplete B cells via antibody-dependent cellular toxicity and inhibit BAFF-R-mediated signals of B cell function and survival.

Identifying specific biomarkers and clinical characteristics is crucial for predicting a patient's response to both existing and emerging treatments for chronic spontaneous urticaria, thereby moving ...

Researchers found significant variability in the dissolution profiles extended-release methylphenidate formulations across manufacturers.

Harrow's Q2 results show promise, but high debt, market challenges, and execution risks loom. Read here for strategies to ...

Switzerland's economic growth slowed sharply in the second quarter, as strong frontrunning of U.S. tariffs in the early part of the year unwound, raising the chance that the Swiss central bank will ...